000 | 01021 a2200289 4500 | ||
---|---|---|---|
005 | 20250516053705.0 | ||
264 | 0 | _c20120109 | |
008 | 201201s 0 0 eng d | ||
022 | _a1473-6551 | ||
024 | 7 |
_a10.1097/WCO.0b013e32834aa3f1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPartridge, Terence A | |
245 | 0 | 0 |
_aImpending therapies for Duchenne muscular dystrophy. _h[electronic resource] |
260 |
_bCurrent opinion in neurology _cOct 2011 |
||
300 |
_a415-22 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aForecasting |
650 | 0 | 4 | _aGene Transfer Techniques |
650 | 0 | 4 |
_aGenetic Therapy _xmethods |
650 | 0 | 4 |
_aGenetic Vectors _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMuscular Dystrophy, Duchenne _xgenetics |
650 | 0 | 4 | _aStem Cells |
650 | 0 | 4 | _aTargeted Gene Repair |
773 | 0 |
_tCurrent opinion in neurology _gvol. 24 _gno. 5 _gp. 415-22 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/WCO.0b013e32834aa3f1 _zAvailable from publisher's website |
999 |
_c21132805 _d21132805 |